1. Sphingolipids as Mediators of Breast Cancer Progression, Metastasis, Response and Resistance to Chemotherapy
   Benjamin Newcomb et al, 2015, Bioactive Sphingolipids in Cancer Biology and Therapy CrossRef
2. Role of the ERK1/2 pathway in tumor chemoresistance and tumor therapy
   Qing-Hua Liu et al, 2015, Bioorganic & Medicinal Chemistry Letters CrossRef
3. Sorafenib in breast cancer treatment: A systematic review and overview of clinical trials
   Menelaos Zafrakas et al, 2016, World Journal of Clinical Oncology CrossRef
4. Angiogenesis Inhibition in Breast Cancer
   Kerem Okutur et al, 2019, Breast Disease CrossRef
5. Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumors
   Frederik Marmé et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef